<a href="https://www.fiercebiotech.com/pharma/novo-reports-cybersecurity-breach-tells-clinical-trial-patients-remain-vigilant" hreflang="en">Novo reports data breach, tells clinical trial patients to 'remain vigilant'</a>
fiercebiotech.com·Jun 11, 2026
Novo Nordisk has reported a data breach affecting some internal IT systems, which exposed de-identified patient information from its clinical trials. The company advises patients to remain vigilant but emphasizes that their core business remains unaffected.
The increase in cybersecurity threats targeting biopharma companies, as evidenced by Novo Nordisk's recent data breach affecting clinical trial patient data, underscores the critical need for robust cybersecurity measures in protecting sensitive information. For those involved in healthtech and biotech, ensuring comprehensive cybersecurity protocols is crucial to safeguard intellectual property and patient data, which could be a significant area of investment and innovation focus.